Flavia M. Sutera
Surrey Research Park
Guildford, ENG GU27YD, United Kingdom
Guildford, ENG GU27YD, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Topical mutant allele-specific siRNA delivery for treatment of Meesmann epithelial corneal dystrophy and elucidation of disease biomarkers.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 11, 2025
TGFBI R124H mutant allele silencing in granular corneal dystrophy type 2 using topical siRNA delivery.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 24, 2024
Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background.
Journal: Calcified tissue international
Published: February 09, 2024
Toward a large-batch manufacturing process for silicon-stabilized lipid nanoparticles: A highly customizable RNA delivery platform.
Journal: Molecular therapy. Methods & clinical development
Published: January 15, 2024
A Study on the Use of the Phyto-Courier Technology in Tobacco Leaves Infected by Agrobacterium tumefaciens.
Journal: International journal of molecular sciences
Published: August 22, 2023
Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans.
Journal: Molecular therapy. Nucleic acids
Published: March 25, 2023
Topical siRNA delivery to the cornea and anterior eye by hybrid silicon-lipid nanoparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 25, 2020
Comparative Study of the Effects Exerted by N-Valproyl-L-Phenylalanine and N-valproyl-L-tryptophan on CA1 Hippocampal Epileptiform Activity in Rat.
Journal: Current pharmaceutical design
Published: December 21, 2017
In situ delivery of corticosteroids for treatment of oral diseases.
Journal: Therapeutic delivery
Published: September 26, 2017
Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability.
Journal: Pharmaceutics
Published: May 26, 2017
Last Updated: 09/26/2026